86 related articles for article (PubMed ID: 17283126)
1. BRCA1 ubiquitinates RPB8 in response to DNA damage.
Wu W; Nishikawa H; Hayami R; Sato K; Honda A; Aratani S; Nakajima T; Fukuda M; Ohta T
Cancer Res; 2007 Feb; 67(3):951-8. PubMed ID: 17283126
[TBL] [Abstract][Full Text] [Related]
2. BRCA1/BARD1 inhibition of mRNA 3' processing involves targeted degradation of RNA polymerase II.
Kleiman FE; Wu-Baer F; Fonseca D; Kaneko S; Baer R; Manley JL
Genes Dev; 2005 May; 19(10):1227-37. PubMed ID: 15905410
[TBL] [Abstract][Full Text] [Related]
3. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.
Nishikawa H; Wu W; Koike A; Kojima R; Gomi H; Fukuda M; Ohta T
Cancer Res; 2009 Jan; 69(1):111-9. PubMed ID: 19117993
[TBL] [Abstract][Full Text] [Related]
4. DNA damage-induced BARD1 phosphorylation is critical for the inhibition of messenger RNA processing by BRCA1/BARD1 complex.
Kim HS; Li H; Cevher M; Parmelee A; Fonseca D; Kleiman FE; Lee SB
Cancer Res; 2006 May; 66(9):4561-5. PubMed ID: 16651405
[TBL] [Abstract][Full Text] [Related]
5. Differential modulation of BRCA1 and BARD1 nuclear localisation and foci assembly by DNA damage.
Brodie KM; Henderson BR
Cell Signal; 2010 Feb; 22(2):291-302. PubMed ID: 19796682
[TBL] [Abstract][Full Text] [Related]
6. Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase.
Sato K; Hayami R; Wu W; Nishikawa T; Nishikawa H; Okuda Y; Ogata H; Fukuda M; Ohta T
J Biol Chem; 2004 Jul; 279(30):30919-22. PubMed ID: 15184379
[TBL] [Abstract][Full Text] [Related]
7. BRCA1/BARD1 ubiquitinate phosphorylated RNA polymerase II.
Starita LM; Horwitz AA; Keogh MC; Ishioka C; Parvin JD; Chiba N
J Biol Chem; 2005 Jul; 280(26):24498-505. PubMed ID: 15886201
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2.
Hayami R; Sato K; Wu W; Nishikawa T; Hiroi J; Ohtani-Kaneko R; Fukuda M; Ohta T
Cancer Res; 2005 Jan; 65(1):6-10. PubMed ID: 15665273
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometric and mutational analyses reveal Lys-6-linked polyubiquitin chains catalyzed by BRCA1-BARD1 ubiquitin ligase.
Nishikawa H; Ooka S; Sato K; Arima K; Okamoto J; Klevit RE; Fukuda M; Ohta T
J Biol Chem; 2004 Feb; 279(6):3916-24. PubMed ID: 14638690
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 DNA-binding activity is stimulated by BARD1.
Simons AM; Horwitz AA; Starita LM; Griffin K; Williams RS; Glover JN; Parvin JD
Cancer Res; 2006 Feb; 66(4):2012-8. PubMed ID: 16489000
[TBL] [Abstract][Full Text] [Related]
11. mRNA Processing Factor CstF-50 and Ubiquitin Escort Factor p97 Are BRCA1/BARD1 Cofactors Involved in Chromatin Remodeling during the DNA Damage Response.
Fonseca D; Baquero J; Murphy MR; Aruggoda G; Varriano S; Sapienza C; Mashadova O; Rahman S; Kleiman FE
Mol Cell Biol; 2018 Feb; 38(4):. PubMed ID: 29180510
[TBL] [Abstract][Full Text] [Related]
12. Interaction of BARD1 and HP1 Is Required for BRCA1 Retention at Sites of DNA Damage.
Wu W; Nishikawa H; Fukuda T; Vittal V; Asano M; Miyoshi Y; Klevit RE; Ohta T
Cancer Res; 2015 Apr; 75(7):1311-21. PubMed ID: 25634209
[TBL] [Abstract][Full Text] [Related]
13. The Histone Variant MacroH2A1 Is a BRCA1Â Ubiquitin Ligase Substrate.
Kim BJ; Chan DW; Jung SY; Chen Y; Qin J; Wang Y
Cell Rep; 2017 May; 19(9):1758-1766. PubMed ID: 28564596
[TBL] [Abstract][Full Text] [Related]
14. The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin.
Wu-Baer F; Lagrazon K; Yuan W; Baer R
J Biol Chem; 2003 Sep; 278(37):34743-6. PubMed ID: 12890688
[TBL] [Abstract][Full Text] [Related]
15. BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.
Fabbro M; Schuechner S; Au WW; Henderson BR
Exp Cell Res; 2004 Aug; 298(2):661-73. PubMed ID: 15265711
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair.
Morris JR; Solomon E
Hum Mol Genet; 2004 Apr; 13(8):807-17. PubMed ID: 14976165
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitination and proteasome-mediated degradation of BRCA1 and BARD1 during steroidogenesis in human ovarian granulosa cells.
Lu Y; Amleh A; Sun J; Jin X; McCullough SD; Baer R; Ren D; Li R; Hu Y
Mol Endocrinol; 2007 Mar; 21(3):651-63. PubMed ID: 17185394
[TBL] [Abstract][Full Text] [Related]
18. Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1.
Rodriguez JA; Schüchner S; Au WW; Fabbro M; Henderson BR
Oncogene; 2004 Mar; 23(10):1809-20. PubMed ID: 14647430
[TBL] [Abstract][Full Text] [Related]
19. The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic function.
Wu-Baer F; Ludwig T; Baer R
Mol Cell Biol; 2010 Jun; 30(11):2787-98. PubMed ID: 20351172
[TBL] [Abstract][Full Text] [Related]
20. Identification of domains of BRCA1 critical for the ubiquitin-dependent inhibition of centrosome function.
Sankaran S; Starita LM; Simons AM; Parvin JD
Cancer Res; 2006 Apr; 66(8):4100-7. PubMed ID: 16618730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
